US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday.
FDA Approves New ADC for HR+, HER2- Breast Cancer
The US Food and Drug Administration (FDA) has approved datopotamab deruxtecan for the treatment of certain patients with unresectable or metastatic hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative breast cancer.
Innovations in Breast Cancer Treatment With Dr Dawn Klemow
Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.
AstraZeneca’s Datroway approved in U.S. for HER2-negative breast cancer patients
DXd, has been approved in the US for the treatment of adult patients with unresectable or metastatic hormone receptor HR-positive, HER2-negative breast cancer who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo. The Anglo-Swedish drugmaker on Friday said that the approval is for adult breast cancer patients who have received prior endocrine-based therapy and chemotherapy for unresectable or metastatic disease.
The Power of Personalized Breast Cancer Care
It’s a sobering statistic: 1 in 8 women in the United States will be diagnosed with breast cancer during her lifetime.1 ...
Young women are almost twice as likely to be diagnosed with cancer as young men: ‘We’re seeing a change’
Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...
Danielle Fishel ‘officially done’ with cancer treatment after 20 rounds of radiation: ‘Hurts to be awake’
Danielle Fishel has completed her breast cancer treatment. The “Boy Meets World” alum, 43, revealed she’s “officially” done ...
Discovery of estrogen receptor 'switches' may aid breast cancer treatment
Researchers at Case Western Reserve University School of Medicine have discovered how specific protein regions contribute to ...
Women on Medicaid at Higher Risk of Breast Cancer
Breast cancer is the second leading cause of cancer death in women. Early detection results in 99% five-year survival rates.
Cancer’s New Face: Younger and Female
Although long considered a disease of aging, certain cancers are turning up more often in younger women, according to a new ...
Cancer death rates decline yet new diagnoses spike for some groups, says report
Cancer diagnoses are expected to exceed two million in 2025, with approximately 618,120 deaths predicted, according to the ...
Medscape1d
Breast Cancer Screening at 40 Seems Cost-Effective in Canada
As cancer treatment costs have increased, identifying and treating early-stage cancer sooner reduces expenses and improves ...
A new report breaks down the alarming rise in cancer among working-age women
In a stunning shift, women under 65 are now more likely than men to get cancer.